Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups.

Jintao Hu, Mei-Wai Fung,Julia Y Tsang,Ivan K Poon,Siu-Ki Chan,Sai-Yin Cheung,Hong Hu,Dongxian Zhou,Gary M Tse

Clinical Breast Cancer（2020）

Cited 6|Views23

No score

Abstract

PPS may provide a more accurate prognostication, mostly among ER/PR+ cancers and with PPS 1A patients. Patients restaged to higher PPS stages showed significant differential survival even within the same PPS. Also, only limited improvement was observed for ER-PR- cancers. Caution needs to be exercised in using PPS for patient prognostication, as in some cases the outcome can be variable with the same PPS.

Translated text

Key words

Anatomical staging,Breast cancer subtypes,Patients’ outcome,Pathological prognostic staging,Tissue microarray

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined